UBS Group’s Lexaria Bioscience Corp. Warrant LEXXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420 | Hold |
4,195
| – | – | ﹤0.01% | 8507 |
|
|
2025
Q1 | $1.58K | Sell |
4,195
-984
| -19% | -$371 | ﹤0.01% | 8168 |
|
|
2024
Q4 | $4.2K | Sell |
5,179
-22,886
| -82% | -$18.5K | ﹤0.01% | 7532 |
|
|
2024
Q3 | $25.8K | Sell |
28,065
-65,657
| -70% | -$60.3K | ﹤0.01% | 6009 |
|
|
2024
Q2 | $75.5K | Buy |
93,722
+93,623
| +94,569% | +$75.5K | ﹤0.01% | 5232 |
|
|
2024
Q1 | $149 | Buy |
+99
| New | +$149 | ﹤0.01% | 7604 |
|
|
2023
Q4 | – | Sell |
-122
| Closed | -$24 | – | 8346 |
|
|
2023
Q3 | $24 | Sell |
122
-251
| -67% | -$49 | ﹤0.01% | 7950 |
|
|
2023
Q2 | $82 | Buy |
+373
| New | +$82 | ﹤0.01% | 7456 |
|
|
2022
Q3 | – | Sell |
-1,061
| Closed | -$1K | – | 9466 |
|
|
2022
Q2 | $1K | Buy |
+1,061
| New | +$1K | ﹤0.01% | 8851 |
|
|
2022
Q1 | – | Sell |
-784
| Closed | -$1K | – | 9406 |
|
|
2021
Q4 | $1K | Buy |
+784
| New | +$1K | ﹤0.01% | 8862 |
|